Journals / Turkish Journal of Pharmaceutical Sciences / 2012 / Cilt: 9 - Sayı: 2

A NOVEL TECHNIQUE TO ENHANCING THE SOLUBILITY AND DISSOLUTION OF FLUTAMIDE USING FREEZE DRYING

Dondurarak Kurutma İle Flutamid'in Çözünürlüğü Ve Çözünme Hızının Artırılması İçin Yeni Bir Teknik

Pages
139–150
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The stability test suggests that, the release profile and drug content of the FDT is almost unchanged as compared with the freshly prepared FDT after 90 days storing.Based on these results, it can be concluded that Flutamide can be formulated in to freeze dried tablets with enhanced solubility and dissolution in water.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Flutamide, an anticancer drug for prostatic carcinoma has poor aqueous solubility and low oral bioavailability.
📊
Key Findings & Data:The drug in FDT is characterized by DSC, XRD and SEM and evaluated for saturation solubility at pH 1.2 and 7.2 .Dissolution studies are carried out andcompared with physical mixture (PM) and pure drug.
💡
Conclusion & Impact:The stability test suggests that, the release profile and drug content of the FDT is almost unchanged as compared with the freshly prepared FDT after 90 days storing.Based on these results, it can be concluded that Flutamide can be formulated in to freeze dried tablets with enhanced solubility and dissolution in water.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Flutamide, an anticancer drug for prostatic carcinoma has poor aqueous solubility and low oral bioavailability. The study aims to enhance the aqueous solubility and dissolution of flutamide by developing a Flutamide freeze dried tablet (FDT). The FDT was prepared by dispersing the drug in an aqueous solution of highly water-soluble carrier materials consisting of gelatin, lysine, and sorbitol. The mixture is poured in to the pockets of blister packs and subjected to freezing and lyophilization. The drug in FDT is characterized by DSC, XRD and SEM and evaluated for saturation solubility at pH 1.2 and 7.2 .Dissolution studies are carried out andcompared with physical mixture (PM) and pure drug. The samples are stored in stability chamber to investigate their physical stability. The DSC and X-ray study implies that crystalline state of Flutamide in FDT is transformed to amorphous state during the formation of FDT. The SEM result suggests reduction in flutamide particle size in FDT (1-4µm) than pure flutamide (19-37 µm). The solubility of Flutamide from the FDT wasnine and half times higher (0.0883 mg/mL) than the pure drug (0.0095 mg/mL) in water. The solubility of flutamide from FDT in both pH 1.2 and 7.has increased to twelve and thirteen times higher than the pure drug. The dissolution studies showed that dissolution of drug from FDT (97.76% at 20 min) was significantly improved compared with the pure drug (29.21% at 60 min). The stability test suggests that, the release profile and drug content of the FDT is almost unchanged as compared with the freshly prepared FDT after 90 days storing.Based on these results, it can be concluded that Flutamide can be formulated in to freeze dried tablets with enhanced solubility and dissolution in water.

Özet

düşük biyoyararlanıma sahiptir. Bu çalışma, dondurularak kurutulmuş flutamid tabletin (FDT) geliştirilerek flutamidin suda çözünürlüğünün ve çözünme hızının artırılmasını amaçlamaktadır. FDT, etkin maddenin jelatin, lizin ve sorbitolden oluşan yüksek derecede suda çözünebilir taşıyıcı maddelerin sulu bir çözeltisi içinde disperse edilmesiyle hazırlanmıştır. Karışım bir blister ambalajın boşluklarına dökülmüş ve dondurma ve liyofilizasyon işlemleri uygulanmıştır. FDT içindeki etkin madde DSC, XRD ve SEM ile incelenmiş ve pH 1.2 ve 7.2'de doygunluk çözünürlüğü değerlendirilmiştir. Çözünme testleri yapılmış ve saf etkin madde ve fiziksel karışım (PM) ile karşılaştırılmıştır. Numuneler, fiziksel stabilitelerinin incelenmesi için bir stabilite kabininde saklanmıştır. DSC ve X-ışını çalışması, FDT oluşumu sırasında FDT içindeki flutamidin kristal halden amorf hale dönüştüğünü göstermiştir. SEM sonucuna göre, saf etkin madde (19-37 µm) ile karşılaştırıldığında FDT içinde flutamidin partikül büyüklüğü (1-4 µm) azalmıştır. FDT'den flutamidin sudaki çözünürlüğü (0.0883 mg/ml), saf etkin maddenin çözünürlüğüne göre (0.0095 mg/ml) 9.5 kat daha yüksek olmuştur. FDT içindeki flutamidin pH 1.2 ve 7.2'deki çözünürlüğü saf etkin maddeninkinden 12 ve 13 kat daha yüksek bulunmuştur. Çözünme testleri, saf etkin madde (60 dakikada %29.21) ile karşılaştırıldığında, FDT'den etkin maddenin çözünme hızının (20 dakikada %97.76) önemli derecede artırıldığını göstermiştir. Stabilite testleri, taze hazırlanan FDT ile karşılaştırıldığında, doksan gün saklama sonrasında FDT'den etkin madde içeriği ve salımının hemen hemen hiç değişmediğini ortaya çıkarmıştır. Bu sonuçlara dayanarak, flutamidin su içinde artan çözünürlüğe ve çözünme hızına sahip dondurularak kurutulmuş tabletlerinin formüle edilebileceği sonucuna varılmıştır.

🔖

Cite This Article

DIXIT, M., KINI, A. G., KULKARNI, P. K., SHIVAKUMAR, H. G. (2012). A NOVEL TECHNIQUE TO ENHANCING THE SOLUBILITY AND DISSOLUTION OF FLUTAMIDE USING FREEZE DRYING. Turkish Journal of Pharmaceutical Sciences, Cilt: 9 - Sayı: 2, 139–150. https://ajindex.com/articles/403827

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Debruyna FM, Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer, Eur Urol 29, 34-36, 1996
  2. Brogden RN, Chrisp P, Flutamide A review of its pharmacodynamics pharmacokinetic properties, and therapeutic use in advanced prostatic cancer, Drug Aging 1, 104-115, 1991
  3. Zuo Z, kwon G, Stevenson B, Diakur J, Wiebe LI, Hydroxypropyl-bcyclodextrin- flutamide inclusion complex. I. Formulation, physical characterization and absorption studies using the Caco-2 in vitro model, J Pharm Pharmaceuti Sci 3, 220-227, 2000
  4. Modasiya MK, Lala II, Prajapati BG, Patel VM, Shah DA, Design and Characterization of Fast Disintegrating Tablets of Piroxicam, Int J PharmTech Res 1(2), 353-357, 2009
  5. Bhupendra GP, Bhaskar P, Formulation, Evaluation and Optimization of Orally Disintegrating Tablet of Piroxicam, Int J PharmTech Res 2(3), 1893-1899, 2010
  6. Farhan AH, Yvonne P, Afzal RM, Formulation and characterisation of lyophilised rapid disintegrating tablets using amino acids as matrix forming agents, Eur J Pharma Bio 5, 254-262, 2010
  7. Muir I, Growing sales and new opportunities for oral fast dissolve. Oral delivery: when you find the Holy Grail, on drug delivery, 4-6, 2007. http://www.ondrugdelivery.com/publications/Oral_Drug_Delivery_07.pdf (accessed 21.11.09
  8. Segar H, Drug delivery products and the Zydis fast dissolving dosage, J. Pharm. Pharmacol, 50, 375-383, 1998
  9. Corveleyn S, Remon J, Formulation of a lyophilised dry emulsion tablet for the delivery of poorly soluble drugs, Int J Pharm 166, 65-74, 1998
  10. Chandrasekhar R, Hassan Z, Al-Husban F, Smith A, Mohammed A, The role of formulation excipients in the development of lyophilized fast-disintegrating tablets, Eur J Pharm Biopharm 72, 119-129, 2009
  11. Tsai G, Yang, P, Chung L, Lange N, Coyle JT, D-Serine added to antipsychotics for the treatment of schizophrenia, Bio Psychiat 44, 1081-1089, 1998
  12. Williams R, Major H, Lock E, Lenz E, Wilson I, D-Serine-induced nephrotoxicity: a HPLC- TOF/MS-based metabonomics approach, Toxicology 207, 179-190, 2005
  13. Friedman M, Chemistry, nutrition, and microbiology of D-amino acids, J Agric Food Chem 47, 3457-3479, 1999
  14. Oh K, Lee E, Kim D, Bae Y, L-Histidine-based pH sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity, Int J Pharm 358, 177-183, 2008
  15. Marrubini G, Caccialanza G, Massolini G, Determination of glycine and threonine in topical dermatologica